Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
Stopped This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised".
Conditions
Interventions
- DRUG: Peramivir 150mg
- DRUG: Peramivir 300mg
Sponsor
BioCryst Pharmaceuticals